Company Tiziana Life London S.E.
Equities
TILS
GB00BKWNZY55
Biotechnology & Medical Research
Business Summary
Number of employees: 9
Managers
Managers | Title | Age | Since |
---|---|---|---|
Gabriele Cerrone
CEO | Chief Executive Officer | 52 | 10/02/98 |
Keeren Shah
DFI | Director of Finance/CFO | 47 | - |
Vaseem Palejwala
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/16 |
Matthew Davis
COO | Chief Operating Officer | - | 30/06/22 |
Paul Spencer
IRC | Investor Relations Contact | - | 30/11/22 |
William Clementi
PRN | Corporate Officer/Principal | - | 31/08/23 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
John Brancaccio
BRD | Director/Board Member | 76 | 30/06/20 |
Willy Simon
BRD | Director/Board Member | 72 | 31/10/15 |
Gabriele Cerrone
CEO | Chief Executive Officer | 52 | 10/02/98 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 194,612,289 | 63,738,859 ( 32.75 %) | 0 | 32.75 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
ACCUSTEM SCIENCES, INC. 11.80% | 1,337,970 | 11.80% | 469,627 $ |
Company contact information
![address Tiziana Life(TILS)](https://cdn.zonebourse.com/static/address/66217415.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+22.15% | 46.56B | |
+45.26% | 41.67B | |
-2.37% | 41.16B | |
+33.84% | 32.4B | |
-6.35% | 28.1B | |
+20.42% | 28.18B | |
+48.83% | 14.52B | |
+45.00% | 13.74B | |
+0.06% | 12.17B |